Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
80 participants
INTERVENTIONAL
2018-09-02
2019-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AS OCT Evaluation for Perforated Punctual Plugs
NCT04624022
Diagnosis of Acquired Punctal Stenosis Using Anterior Segment Optical Coherence Tomography
NCT03498144
Stellest Lenses and Low-concentration Atropine Myopia Control Among Children
NCT06344429
The Exploratory Clinical Trials on the Primary Safety and Effectiveness of High Myopic Posterior Scleral Fixation System
NCT05034016
Systemic Erythropoietin Injection in Patients Having Optic Atrophy
NCT04680143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Methylprednisolone eye drops
Preservative free steroids methylprednisolone 5% eye drops (prepared by dilution of methyleprednisolone 500mg in 10 ml distilled water (Solu-Medrol, Pfizer company) was prepared and given for all enrolled cases by the following regimen 5 times/day for 5 days with gradual decrease every third day over the following 2 weeks
Methylprednisolone eyedrops
instillation of methylprednisolone eye drops
distilled water eyedrops
Distilled water eyedrops instilled 3 times per day for two weeks
Methylprednisolone eyedrops
instillation of methylprednisolone eye drops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methylprednisolone eyedrops
instillation of methylprednisolone eye drops
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Lid margin malposition such as ectropion, entropion or lid retraction.
* Medial lid masses obscuring punctum.
* History of ocular trauma involving lid margin or punctum.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr Mahmoud Awara
assistant professor of ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amr Awara
Tanta, Gharbeyia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32399/09/18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.